Intracerebral injection of IL-4 and IL-13 reduced amyloid β plaque load in APP23 mice with Alzheimer’s disease. The decrease was accompanied with improved cognition and upregulation of Arg1 and YM1 positive M2 cells. This evidence concerns the gene IL4 and early-onset autosomal dominant Alzheimer disease.